Düsseldorf, Germany

Anja Förster

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Virbac Corporation. Active years: 2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anja Förster: Innovator in Pharmaceutical Development

Introduction

Anja Förster is a notable inventor based in Düsseldorf, Germany. She has made significant contributions to the field of pharmaceuticals, particularly with her innovative work on drug formulations. Her expertise and dedication to research have led to the development of a unique patent that showcases her skills as an inventor.

Latest Patents

Anja Förster holds a patent for a tablet comprising modoflaner as an active component. This invention relates to a crystalline modification of Modoflaner, specifically the compound 6-fluoro-N-(3-(2-iodo-4-(perfluoropropan-2-yl)-6-(trifluoromethyl)phenylcarbamoyl)-2-fluorophenyl)nicotinamide. This innovative formulation has the potential to enhance the efficacy of treatments in the pharmaceutical industry.

Career Highlights

Anja Förster is currently employed at Virbac Corporation, where she continues to push the boundaries of pharmaceutical research. Her work at Virbac has allowed her to collaborate with other talented professionals in the field, further enriching her experience and contributions to innovative drug development.

Collaborations

Anja has worked alongside notable colleagues such as Fabian Simons and Britta Olenik. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in their respective projects.

Conclusion

Anja Förster is a remarkable inventor whose work in pharmaceuticals exemplifies innovation and dedication. Her patent for modoflaner demonstrates her commitment to improving drug formulations, and her collaborations with talented coworkers further enhance her contributions to the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…